AR029544A1 - Composiciones y metodos para tratar infecciones bacterianas - Google Patents
Composiciones y metodos para tratar infecciones bacterianasInfo
- Publication number
- AR029544A1 AR029544A1 ARP010103125A ARP010103125A AR029544A1 AR 029544 A1 AR029544 A1 AR 029544A1 AR P010103125 A ARP010103125 A AR P010103125A AR P010103125 A ARP010103125 A AR P010103125A AR 029544 A1 AR029544 A1 AR 029544A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- compositions
- bacterial infections
- treat bacterial
- sulbactam
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composicion que tiene actividad antibacteriana. Más particularmente, una mezcla de un compuesto de oxazolidinona, sulbactam y agentes activos de ampicilina, que demuestran actividad contra las cepas resistentes de la bacteria. Métodos para utilizar el compuesto de oxazolidinona, sulbactam y ampicilina para tratar una infeccion bacteriana.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21541800P | 2000-06-30 | 2000-06-30 | |
US23277300P | 2000-09-15 | 2000-09-15 | |
US27930601P | 2001-03-28 | 2001-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR029544A1 true AR029544A1 (es) | 2003-07-02 |
Family
ID=27396119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103125A AR029544A1 (es) | 2000-06-30 | 2001-06-29 | Composiciones y metodos para tratar infecciones bacterianas |
Country Status (14)
Country | Link |
---|---|
US (1) | US6544991B2 (es) |
EP (1) | EP1301207B1 (es) |
JP (1) | JP2004501965A (es) |
AR (1) | AR029544A1 (es) |
AT (1) | ATE301474T1 (es) |
AU (1) | AU2001272961A1 (es) |
DE (1) | DE60112581T2 (es) |
DK (1) | DK1301207T3 (es) |
ES (1) | ES2245698T3 (es) |
MY (1) | MY128739A (es) |
PE (1) | PE20020295A1 (es) |
PT (1) | PT1301207E (es) |
TW (1) | TWI265030B (es) |
WO (1) | WO2002002095A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
IL164195A0 (en) * | 2002-03-29 | 2005-12-18 | Upjohn Co | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
BRPI0611070A2 (pt) * | 2005-05-06 | 2010-08-03 | Wyeth Corp | composição; composição farmacêutica; terapia de combinação; aparelho médico; método para a administração de pelo menos uma glicilciclina e pelo menos uma heparina; método para a administração de glicilciclina e heparina; método de tratamento de infecções intra-abdominais com complicações (ciai) e infecções cutáneas e da estrutura cutánea com complicações (csssi) causadas por patógenos gram negativos e gram positivos, anaeróbios e cepas tanto suscetìveis a meticilina quanto aquelas resistentes a meticilina de staphylococcus aureus (mssa e mrsa); método de tratamento de infecções intra-abdominais com complicações (ciai) e infecções cutáneas e da estrutura cutánea com complicações (csssi) causadas por patógenos gram negativos e gram positivos, anaeróbios e cepas tanto suscetìveis a meticilina quanto as resistentes a meticilina de staphylococcus aureus (mssa e mrsa) em um paciente que dele necessite; método de administração de antibiótico; artigo de fabricação; kit; uso de uma glicilcilina de fórmula i ou seu sal farmaceuticamente aceitável; uso de uma heparina ou seu sal farmaceuticamente aceitável; e produto |
ES2335307T3 (es) | 2005-06-29 | 2010-03-24 | PHARMACIA & UPJOHN COMPANY LLC | Homomorfolin oxalidinonas como agentes antibacterianos. |
WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
EP2367820B1 (en) | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Novel antimicrobial agents |
US8906913B2 (en) | 2009-06-26 | 2014-12-09 | Panacea Biotec Limited | Azabicyclohexanes |
WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
BE641785A (es) | 1962-12-26 | |||
US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
NZ315469A (en) | 1995-09-01 | 2000-01-28 | Upjohn Co | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
ES2166073T3 (es) | 1996-04-11 | 2002-04-01 | Upjohn Co | Procedimiento para preparar oxazolidinonas. |
KR100619639B1 (ko) | 1997-11-07 | 2006-09-06 | 파마시아 앤드 업존 캄파니 엘엘씨 | 옥사졸리디논의 제조 방법 |
NZ513292A (en) | 1999-02-01 | 2003-08-29 | Upjohn Co | Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
-
2001
- 2001-06-21 DK DK01952176T patent/DK1301207T3/da active
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en active IP Right Grant
- 2001-06-21 AT AT01952176T patent/ATE301474T1/de not_active IP Right Cessation
- 2001-06-21 ES ES01952176T patent/ES2245698T3/es not_active Expired - Lifetime
- 2001-06-21 PT PT01952176T patent/PT1301207E/pt unknown
- 2001-06-21 DE DE60112581T patent/DE60112581T2/de not_active Expired - Fee Related
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/ja active Pending
- 2001-06-21 EP EP01952176A patent/EP1301207B1/en not_active Expired - Lifetime
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/es not_active Application Discontinuation
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
- 2001-06-29 TW TW090115958A patent/TWI265030B/zh not_active IP Right Cessation
- 2001-06-29 AR ARP010103125A patent/AR029544A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1301207B1 (en) | 2005-08-10 |
US6544991B2 (en) | 2003-04-08 |
JP2004501965A (ja) | 2004-01-22 |
DE60112581T2 (de) | 2006-06-01 |
ATE301474T1 (de) | 2005-08-15 |
MY128739A (en) | 2007-02-28 |
WO2002002095B1 (en) | 2004-03-25 |
AU2001272961A1 (en) | 2002-01-14 |
DK1301207T3 (da) | 2005-10-10 |
WO2002002095A3 (en) | 2003-02-06 |
DE60112581D1 (de) | 2005-09-15 |
US20020022610A1 (en) | 2002-02-21 |
PT1301207E (pt) | 2005-11-30 |
TWI265030B (en) | 2006-11-01 |
ES2245698T3 (es) | 2006-01-16 |
WO2002002095A2 (en) | 2002-01-10 |
EP1301207A2 (en) | 2003-04-16 |
PE20020295A1 (es) | 2002-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR029544A1 (es) | Composiciones y metodos para tratar infecciones bacterianas | |
NO20052787L (no) | N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
NO20042271L (no) | Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder | |
UY26380A1 (es) | Inhibidores de fab i | |
BR0210791A (pt) | Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma | |
PL404913A1 (pl) | Zwiazek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy | |
NO20065836L (no) | Linezolidkrystallform | |
FI963232A0 (fi) | Antimikrobisena aineena käytettävä hapotettu nitriitti | |
CR9056A (es) | Composiciones que contienen piperacilina, tazobactam y un acido aminocarboxilico en un diluyente de lactato de sodio | |
NO20052788L (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
ATE461928T1 (de) | Antibakterielle wirkstoffe | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
BR0113634A (pt) | Antibióticos de cefalosporina e suas pró-drogas | |
UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
CL2021002992A1 (es) | Métodos y composiciones que comprenden variantes de la proteína a de estafilococos (spa) | |
ATE311885T1 (de) | Monobactam-antibakterielle verbindungen und anwendungsverfahren | |
DOP2002000449A (es) | Sal sodica de un inhibidor de integradasa del vih. | |
UY26814A1 (es) | Método y composición | |
BR0316245A (pt) | Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos | |
CL2004001343A1 (es) | Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. | |
BR0214494A (pt) | Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos | |
ATE312839T1 (de) | Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |